docetaxel anhydrous has been researched along with Capillary Leak Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Yang, J; Zhang, F | 1 |
| Amathieu, R; Dhonneur, G; Fessenmeyer, C; Tual, L | 1 |
| Aamdal, S; Oian, P; Semb, KA | 1 |
3 other study(ies) available for docetaxel anhydrous and Capillary Leak Syndrome
| Article | Year |
|---|---|
Trastuzumab-induced systemic capillary leak syndrome in a breast cancer patient.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Capillary Leak Syndrome; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Middle Aged; Taxoids; Trastuzumab | 2014 |
[Docetaxel-induced acute pulmonary capillary-leak syndrome mimicking cardiogenic oedema].
Topics: Acute Disease; Anticoagulants; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Capillary Leak Syndrome; Diagnosis, Differential; Docetaxel; Dose-Response Relationship, Drug; Edema, Cardiac; Female; Heparin, Low-Molecular-Weight; Humans; Lung Neoplasms; Methylprednisolone; Middle Aged; Pulmonary Edema; Pulmonary Embolism; Recurrence; Respiration, Artificial; Spinal Neoplasms; Taxoids; Tinzaparin | 2007 |
Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment.
Topics: Adult; Antineoplastic Agents, Phytogenic; Body Weight; Capillary Leak Syndrome; Capillary Permeability; Carcinoma, Non-Small-Cell Lung; Docetaxel; Edema; Female; Hemodynamics; Humans; Lung Neoplasms; Male; Paclitaxel; Prospective Studies; Taxoids | 1998 |